Navigation Links
USCCB Official Praises Senate Passage of 'Genetic Information Nondiscrimination Act'
Date:4/24/2008

WASHINGTON, April 24 /PRNewswire-USNewswire/ -- The U.S. Senate voted 95 to 0 to pass the Genetic Information Nondiscrimination Act ("GINA," H.R. 493), which bars employers and health insurers from discriminating against individuals on the basis of their own or their family members' genetic information, on April 24.

Deirdre McQuade, Assistant Director for Policy and Communications at the U.S. Conference of Catholic Bishops' (USCCB) Secretariat of Pro-Life Activities, praised its passage.

"Today the Senate took a stand for some of the most vulnerable members of the human family, whether born, yet to be born, or placed for adoption. No one should be discriminated against on the basis of genetic testing," McQuade said.

The House of Representatives overwhelmingly passed a nearly identical bill by a vote of 420 to 3 on April 25, 2007.

"The Pro-Life Secretariat is particularly grateful to Rep. Bart Stupak (D-MI) for ensuring that this bill's protection against discrimination will cover the families of unborn children with adverse prenatal diagnoses, as well as children being adopted," she said. "His advocacy on their behalf will empower families to welcome vulnerable children with special needs into their lives."

"After minor technical differences between the House and Senate bills are resolved, we look forward to President Bush signing into law this important protection for American families," McQuade said.


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat forPro-Life
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
3. Chocolate Milk: The Official Drink of Halloween
4. Easter Seals Awards State and Municipal Public Officials With 2007 Outstanding Advocate Awards
5. D.I.S.C. Scores First Sponsorship Deal as Official Medical Center of the Los Angeles Kings
6. New data on hormone therapy must lead to re-evaluation of official guidelines
7. XTL Announces Delisting From the Official List of the United Kingdom Listing Authority
8. Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA
9. Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Legislators, Health Officials, Breast Cancer Survivors and Activists Call for Action on Breast Cancer
10. Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
11. CDC Reports that Adult Smoking Declines Have Stalled; Elected Officials Should Step up Fight Against Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
... composed of polymer layers and nanoparticles may ...without harming the rest of the body, according to...m could be robust and flexible enough to deliver a...te student, chemical engineering. "The drugs are p...
...ickly becoming the "it" nutrient with health benef...heart disease and now diabetes. , A recent revi...iversity Chicago Marcella Niehoff School of Nursin...nosed. These findings appeared in the latest issu...
...rsity of Arizona are developing a set of standardi...ith Down syndrome. , The condition, which occurs...ths, is signaled by the presence of an extra 21st ...early onset of Alzheimer,s dementia. New research ...
... be paid after hospital discharge, , , MON...the veterans treated in Veterans Affairs hospitals...ter risk of suicide than non-depressed veterans, ...esearchers wondered? , Their five-year study of v...
...l Year 2008 Earnings Conference Call , Thursday, F...ZER, Pa., Jan. 12 Cephalon, Inc . (Nasdaq: CEP...onference call covering fourth quarter and full ye... will be distributed by PRNewswire , 4:50 p.m. EST...
...a worthy cause at Access Hollywood,s 3rd Annual "S...Lollipop Theater Network. , , LOS ANGELES, Jan. 1..., once again donated $100,000 to two important cha...onsecutive beauty sponsorship of the lounge, which...
Other Medicine News:Health News:Tiny capsules deliver 2Health News:Vitamin D is the 'it' nutrient of the moment 2Health News:Standardized test battery to aid those with Down syndrome 2Health News:Standardized test battery to aid those with Down syndrome 3Health News:Standardized test battery to aid those with Down syndrome 4Health News:Standardized test battery to aid those with Down syndrome 5Health News:Standardized test battery to aid those with Down syndrome 6Health News:With Depression, Vets Face Higher Suicide Risk 2Health News:With Depression, Vets Face Higher Suicide Risk 3Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 2Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 3
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...s,Inc. (Amex: IMM ) is pleased to announce today ...h as a strategic advisor. General Clark will,provi...pany develops its,drug programs targeting various ...tion and treatment. General Clark is one of the c...ers and a respected international voice in public ...
...ry biliary cirrhosis patient,has the biomarker of ...nic,researchers have found that first-degree relat...s with primary biliary cirrhosis (PBC) are,more li... blood. Armed with,this new information, physician...f PBC patients with a simple blood test, enabling ...
Other Medicine Technology:General Wesley Clark Joins Immtech as Consulting Strategic Advisor 2General Wesley Clark Joins Immtech as Consulting Strategic Advisor 3New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2
DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
DNA Engine Thermal Cycler Chassis
MBS Satellite Thermal Cycler 0.5ml
MBS Satellite Thermal Cycler 0.2ml
Medicine Products: